Adults taking the novel once-daily oral pill for plaque psoriasis had significantly higher rates of clear or almost clear ...
The Boston-based biotech said today that the orally ... for antibody-based therapies from Biogen, Roche/Prothena and AbbVie. Inhibikase Therapeutics is meanwhile running early-stage trials of ...
US drugmaker AbbVie has agreed to buy struggling Allergan in a $63 billion deal that continues a slew of multibillion dollar takeovers in the biopharma sector this year. AbbVie is stumping up more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback